Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Cash from Investing Activities (2016 - 2019)

Historic Cash from Investing Activities for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to $103000.0.

  • Soleno Therapeutics' Cash from Investing Activities rose 15919.54% to $103000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $528000.0, marking a year-over-year increase of 17164.18%. This contributed to the annual value of -$225.7 million for FY2024, which is N/A changed from last year.
  • As of Q4 2019, Soleno Therapeutics' Cash from Investing Activities stood at $103000.0, which was up 15919.54% from $441000.0 recorded in Q3 2019.
  • Over the past 5 years, Soleno Therapeutics' Cash from Investing Activities peaked at $441000.0 during Q3 2019, and registered a low of -$1.3 million during Q3 2015.
  • Its 5-year average for Cash from Investing Activities is -$98278.6, with a median of -$8000.0 in 2019.
  • As far as peak fluctuations go, Soleno Therapeutics' Cash from Investing Activities tumbled by 180000.0% in 2016, and later surged by 892000.0% in 2019.
  • Over the past 5 years, Soleno Therapeutics' Cash from Investing Activities (Quarter) stood at -$31777.0 in 2015, then soared by 101.01% to $320.0 in 2016, then soared by 4587.5% to $15000.0 in 2017, then crashed by 1260.0% to -$174000.0 in 2018, then soared by 159.2% to $103000.0 in 2019.
  • Its last three reported values are $103000.0 in Q4 2019, $441000.0 for Q3 2019, and -$6000.0 during Q2 2019.